Showing 1851-1860 of 9394 results for "".
Strategies for Treating Patients on GLP-1 Receptor Agonists and More
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/strategies-for-treating-patients-on-glp-1-receptor-agonists-and-more/54646/Suneel Chilukuri, MD, discusses key takeaways from the “What’s My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium” workshop at Maui Derm Hawaii 2026.Lose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Revisiting Facial Seborrheic Dermatitis: A New Therapeutic Option
https://practicaldermatology.com/topics/general-topics/PD0109_05-php/22892/A popular topical agent offers anti-inflammatory, antibacterial, and sebosuppressive effects that could prove useful for management of seborrheic dermatitis.Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Acne and Rosacea: Quality of Life and Lifestyle Insights
https://practicaldermatology.com/topics/acne-rosacea/acne-and-rosacea-quality-of-life-and-lifestyle-insights/23516/Acne and rosacea have causes and effects well beyond the skin.Topical Steroid Withdrawal in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-steroid-withdrawal-in-atopic-dermatitis/23079/Exploring the important role and proper use of topical corticosteroids in the management of eczema.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivSunscreen News, Views, and Miscues
https://practicaldermatology.com/topics/skin-cancer-photoprotection/sunscreen-news-views-and-miscues/23036/What your patients—and you—should know about the latest developments around sunscreens.Alternative Therapies for the Treatment of Acne
https://practicaldermatology.com/topics/acne-rosacea/alternative-therapies-for-the-treatment-of-acne/23787/Many patients are interested in alternative options instead of or alongside prescription acne treatments.Breaking the Itch-Scratch Cycle
https://practicaldermatology.com/topics/atopic-dermatitis/breaking-the-itch-scratch-cycle/23922/Upadacitinib’s rapid relief for patients with moderate-to-severe atopic dermatitis.